STOCK TITAN

Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Bausch Health Companies Inc. (NYSE/TSX: BHC) announced that key executives will participate in the Goldman Sachs Leveraged Finance Conference on June 25, 2020, at 11:25 a.m. EDT. The executives include Paul S. Herendeen, Arthur J. Shannon, and William Woodfield. A live webcast and audio archive will be available on the company’s Investor Relations page. Bausch Health aims to enhance lives through its diverse healthcare products, focusing on eye health, gastroenterology, and dermatology.

Positive
  • None.
Negative
  • None.

LAVAL, Quebec, June 16, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Paul S. Herendeen, executive vice president and chief financial officer, Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, and William Woodfield, vice president and treasurer, are scheduled to participate at the virtual Goldman Sachs Leveraged Finance Conference on June 25, 2020, at 11:25 a.m. EDT.

A live webcast and audio archive of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. web site at: http://ir.bauschhealth.com/events-and-presentations/2020.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

arthur.shannon@bauschhealth.com

lainie.keller@bauschhealth.com

(514) 856-3855

(908) 927-1198

(877) 281-6642 (toll free)


 

"Bausch

"Cision" View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-to-participate-at-goldman-sachs-annual-leveraged-finance-conference-301075178.html

SOURCE Bausch Health Companies Inc.

FAQ

When will Bausch Health participate in the Goldman Sachs Leveraged Finance Conference?

Bausch Health will participate in the Goldman Sachs Leveraged Finance Conference on June 25, 2020, at 11:25 a.m. EDT.

Who will represent Bausch Health at the Goldman Sachs conference?

Paul S. Herendeen, Arthur J. Shannon, and William Woodfield will represent Bausch Health at the conference.

Where can I watch the Bausch Health conference webcast?

The live webcast can be accessed on the Investor Relations page of Bausch Health.

What is Bausch Health's focus in healthcare?

Bausch Health develops products primarily in the areas of eye health, gastroenterology, and dermatology.

Bausch Health Companies Inc.

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Stock Data

3.17B
367.80M
11.08%
77.48%
3.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
QUEBEC